LETTERS FOR ISSUE ON
|
|
|
- Hugh Hodges
- 6 years ago
- Views:
Transcription
1 S FOR ISSUE ON LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS M/S PANACEA BIOTECH LTD 3299, APPROVAL M/S HIPRA INDIA PVT, LTD APPROVAL M/S LUPIN LIMITED APPROVAL M/S BHARAT SERUM AND VACCINE LTD 7218 AMENDMENT SHELF LIFE S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. NOSCH LABS PVT. LTD NIL 2. SUN PHARMACEUTICAL INDUSTRIAL LTD BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT. LTD., NAVI MUMBAI M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT. LTD., NAVI MUMBAI APPROVAL APPROVAL
2 3. M/S. ALEMBIC PHARMACEUTICALS LTD., VADODARA M/S. ALEMBIC PHARMACEUTICALS LTD., VADODARA M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA LTD., HYDERABAD M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA LTD., HYDERABAD M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA LTD., HYDERABAD APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL 8. M/S. CIPLA LIMITED, MUMBAI APPROVAL 9. M/S. CIPLA LIMITED, MUMBAI APPROVAL 10. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD- 11. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD- 12. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD- 13. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD- 14. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD- 15. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD- 16. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD- 17. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD- 18. M/S. GLENMARK PHARMACEUTICALS LTD., NAVI MUMBAI M/S. GLENMARK PHARMACEUTICALS LTD., NAVI MUMBAI M/S. GLENMARK PHARMACEUTICALS LTD., NAVI MUMBAI APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL
3 21. M/S. HETERO LABS LTD., HYDERABAD APPROVAL 22. M/S. LAMBDA THERAPEUTIC RESEARCH LTD., AHMEDABAD M/S. LAMBDA THERAPEUTIC RESEARCH LTD., AHMEDABAD M/S. LAMBDA THERAPEUTIC RESEARCH LTD., AHMEDABAD M/S. LAMBDA THERAPEUTIC RESEARCH LTD., AHMEDABAD M/S. LAMBDA THERAPEUTIC RESEARCH LTD., NAVI MUMBAI M/S. LAMBDA THERAPEUTIC RESEARCH LTD., NAVI MUMBAI APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL 28. M/S. LOTUS LABS PVT. LTD., BANGALORE APPROVAL 29. M/S. LOTUS LABS PVT. LTD., BANGALORE APPROVAL 30. M/S. LOTUS LABS PVT. LTD., BANGALORE APPROVAL 31. M/S. LOTUS LABS PVT. LTD., BANGALORE APPROVAL 32. M/S. LOTUS LABS PVT. LTD., BANGALORE APPROVAL 33. M/S. LOTUS LABS PVT. LTD., BANGALORE APPROVAL 34. M/S. LOTUS LABS PVT. LTD., CHENNAI APPROVAL 35. M/S. LUPIN LIMITED (RESEARCH PARK), PUNE APPROVAL 36. M/S. LUPIN LIMITED (RESEARCH PARK), PUNE APPROVAL 37. M/S. MACLEODS PHARMACEUTICALS LTD., ANDHERI 38. M/S. MACLEODS PHARMACEUTICALS LTD., ANDHERI 39. M/S. MACLEODS PHARMACEUTICALS LTD., ANDHERI 40. M/S. MACLEODS PHARMACEUTICALS LTD., ANDHERI 41. M/S. MACLEODS PHARMACEUTICALS LTD., ANDHERI APPROVAL 2526 APPROVAL 1668 APPROVAL 1667 APPROVAL APPROVAL
4 42. M/S. MANIPAL ACUNOVA LTD., MANGALORE APPROVAL 43. M/S. MICRO THERAPEUTIC RESEARCH LABS PVT. LTD., COIMBATORE M/S. NORWICH CLINICAL SERVICES PVT. LTD., BANGALORE APPROVAL APPROVAL 45. M/S. PANACEA BIOTEC LTD., PUNJAB FTS NO TEST LICENCE 46. M/S. PANEXCELL CLINICAL LAB PVT. LTD., NAVI MUMBAI M/S. RA CHEM PHARMA LTD., BALANAGAR, HYDERABAD M/S. SEMLER RESEARCH CENTER PVT. LTD., BANGALORE M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., HARYANA 50. M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., HARYANA 51. M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA M/S. VEEDA CLINICAL RESEARCH PVT. LTD., 53. M/S. VEEDA CLINICAL RESEARCH PVT. LTD., 54. M/S. VEEDA CLINICAL RESEARCH PVT. LTD., 55. M/S. VEEDA CLINICAL RESEARCH PVT. LTD., APPROVAL APPROVAL 5106 APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL FDC DIVISION S.NO. NAME OF COMPANY DIARY NO DOCUMENT 1. M/S. SYNOKEM PHARMACEUTICALS, M/S. AKUMS DRUGS & PHARMACEUTICALS 7681 COSMETICS DIVISION
5 S.NO. NAME OF THE FIRM DIARY NO. STATUS 1. M/S. VOV INTERNATIONAL, MAHARASHTRA 2. M/S. MICHAEL TRADERS, TAMILNADU 3. M/S. AURORA TRADING, NEWDELHI DEFICIENCY DEFICIENCY DEFICIENCY SUBSEQUENT NEW DRUG S. NO. NAME OF THE FIRM REFERENCE NO. FTS NO. TYPE OF 1. M/S THINQ PHARMA CRO LTD., TEST LICENSE/ CT NOC (2) GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. NOVARTIS 50889/37347 CT NOC & TL APPROVAL 2 M/S. JSS TL APPROVAL MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. STRYKER INDIA PVT. LTD APPROVAL (E-RC) 2. M/S. GOLDWIN MEDICARE LTD. FTS. NO CLARIFICATION 3. M/S. TOSHBRO MEDICALS PVT. LTD. FTS. NO CLARIFICATION 4. M/S. TTK PROTECTIVE DEVICE LIMITED FTS. NO.- QUERY
6 5. DR. INDERJEET SINGH HURA, ADC(I) M/S SHANKHESHWAR IMPEX PRIVATE LIMITED 6. THE STATE DRUGS CONTROLLER, PANCHKULA (CLAA) GHAZIABAD (CLAA) (M/S. LARS MEDICARE PVT. LTD., SONEPAT) 7. THE STATE DRUGS CONTROLLER, PANCHKULA (CLAA) GHAZIABAD (CLAA) (M/S. HARSORIA HEALTHCARE PVT. LTD., GURGAON) 8. THE STATE DRUGS CONTROLLER, PANCHKULA (CLAA) GHAZIABAD (CLAA) (M/S. MEDI PLUS INDIA LTD., BAHADURGARH) 9. THE COMMISSIONER, GANDHINAGAR (CLAA) AHMEDABAD (CLAA) THE DRUGS CONTROLLER & LICENSING AUTHORITY, JAIPUR (CLAA) 10. THE COMMISSIONER, GANDHINAGAR (CLAA) GANDHINAGAR (CLAA) THE DRUGS CONTROLLER & LICENSING AUTHORITY, AHMEDABAD NIL FTS. NO FTS. NO FTS. NO NIL FTS NO APPROVAL APPROVAL APPROVAL
7 (CLAA) DIAGNOSTICS DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ABBOTT HEALTHCARE PVT. LTD APPROVAL (RENEWAL-RC) 2. M/S. CADILA HEALTHCARE LTD M/S VISHAT DIAGNOSTIC PVT LTD., QUERY 4. M/S VISHAT DIAGNOSTIC PVT. LTD., 7486 QUERY 5. M/S VISHAT DIAGNOSTIC PVT LTD., QUERY 6. M/S VISHAT DIAGNOSTIC PVT LTD 7801 QUERY 7. M/S GEUINE BIOSYSTEM FTS NO SH. N.C BAKSHI FTS NO QUERY NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. CADILA HEALTHCARE LTD. - (3) 2. M/S. ALKEM LABORATORIES LTD. - QUERY 3. M/S. IND-SWIFT LTD. - QUERY 4. M/S. MICRO LABS LTD. - QUERY 5. M/S. AJANTA PHARMA LIMITED - QUERY 6. M/S. HETERO LABS LTD - QUERY 7. M/S BOEHRINGER INGELHEIM INDIA PVT LTD -
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC
LETTERS FOR ISSUE ON
S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.
LETTERS FOR ISSUE ON
S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS
LETTERS FOR ISSUE ON
S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,
LETTERS FOR ISSUE ON
S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.05.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH MUMBAI-400709 2. M/S. ACCUTEST RESEARCH MUMBAI-400709 3. M/S. ACCUTEST RESEARCH MUMBAI-400709
LETTERS FOR ISSUE ON
S FOR ISSUE ON 19.06.2015 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 2. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT.,
LETTERS FOR ISSUE ON
S FOR ISSUE ON 04.10.2017 MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14608 QUERY 2. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14609 QUERY 3. DR. ULHAS
TODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
LETTERS FOR ISSUE ON
S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD
LETTERS FOR ISSUE ON
S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL
LETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 27.12.2017 LVP DIVISION S. NO. COMPANY NAME FTS NO. /Diary No. STATUS 01 M/s. Akums Drugs & Pharmaceuticals, Haridwar 02 M/s. Unique Pharmaceutical Laboratories,Guj. (License No.4)
LETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
1 Agio Pharmaceuticals Limited 15/31/2013-EP(Engg) dt:21.11.2013 7,98,217.00 2 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg) dt:21.11.2013 15,10,268.00 3 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg)
RESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF JUNE-2016 DATE OF HEARING 13.06.2016 1. 934855/05 Opp. AMD-245342 M/s. Ajanta Pharma Limited, Mumbai / Mr. Manoj G. Menda, Mumbai
Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33
Computataion of Retail Price based on Jan.-2016 Data under Para 4 of DPCO 2013 Cholecalciferol 800 IU Drops of M/s Raptakos, Brett & Co.Ltd. Number of Companies cosisting of Market Share of 1% & Above
File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division
Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution
Recent trends and challenges
INTERNATIONAL CONFERENCE ON Recent trends and challenges in Bioanalysis Tentative Program Bioanalytica-2017 Hyderabad,India JUNE 30, 2017 Invitation ABC Biologics welcomes you to attend the international
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Fri, 19 Apr 2019 13:49:20 GMT) CTRI Number CTRI/2009/091/000126 [Registered on: 15/04/2009] - Last Modified On 03/09/2014 Post Graduate Thesis Type of Trial
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 02 Sep 2018 23:38:24 GMT) CTRI Number Last Modified On 05/02/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
New: Li st of TPAs List of TPA's released by IRDA Updated C on Oct lick Here.
TPA List In India // Third Party Administrators for Health Insurance are a link between the insured A Third Party Administrator is the same as an ASO - administrative services only company. The duties
BRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
Education. Current Activities
Nirali Mehta, M.Sc., M.Phil. Founder & Consultant Biostatistician Ahmedabad, Gujarat, India. M +91 9377060504 E nirali.mehta@pharma-stats.in W www.pharma-stats.in Education 1998-2001 Bachelor of Science
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex,
Companies Database, Mobile Database, Id Database, Credit
m All India Database We Provides Database Companies Database, Mobile Database, Email Id Database, Credit Card Holder Database, Corporate database, CEO s Database, Corporate Employee Database, Car s Owner
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016 RECOMBINANT PRODUCTS S. No. Firm Name of Formulation Import License No. &
Recommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division
Recommetions of thesec (Dermatology & Allergy) made in its 23 rd meeting held on 11.05.2017 at CDSCO HQ New Delhi: File /Drug Name Recommetions New Drugs Division 1 12-28/15-DC (Pt-B) Apremilast 10/20/30
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities)
Edition: Version 11-19th of July 2018 List of A & B Products List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) As from the version
INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION ROUND-2
G B Pant Hospital J L Nehru Marg, Delhi Cardiac Anaesthesia 1 Delhi-110002 Indraprastha s Delhi Cardiac Anaesthesia 1 Medanta- The Medicity Sector-38, Gurgaon, Haryana Cardiac Anaesthesia 5 Haryana-122001
Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
Case 3:15-cv-05982-PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 Liza M. Walsh Christine I. Gannon CONNELL FOLEY LLP One Newark Center 1085 Raymond Boulevard, 19th Floor Newark, New Jersey
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015 S. No. Firm Name of Formulation Registration Certificate No. & Validity 1. M/s. Nirlac Chemicals,14 th
Rapid Life Drugs & Healthcare
+91-8048948845 Rapid Life Drugs & Healthcare https://www.rapidlife.net/ We are amongst the leading manufacture, traders, distributors and suppliers of this impeccable and diverse range of Pharmaceutical
CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 07 Oct 2018 22:54:26 GMT) CTRI Number Last Modified On 11/05/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 07 Oct 2018 14:20:17 GMT) CTRI Number Last Modified On 13/02/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Ameya works predominantly in the architectural design, interiors and project management segments in healthcare industry
Introduction Ameya design is premier health care consultancy firm with experience with design and execution of largest number of private sector health care facility in India. Key Information Ameya works
ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore.
MINUTES OF THE 6 th MEETING OF TECHNICAL COMMITTEE HELD ON 25-07-2013 UNDER CHAIRMANSHIP OF DGHS FOR SUPERVISING CLINICAL TRIALS ON NEW CHEMICAL ENTITIES IN THE LIGHT OF DIRECTIONS OF THE HON BLE SUPREME
New Delhi, the 18 th December, 2017 ORDER
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules
Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules The prices listed below are Average Wholesale Prices ( AWP ) as established and made
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Fri, 01 Feb 2019 09:32:33 GMT) CTRI Number CTRI/2011/091/000008 [Registered on: 20/01/2011] - Last Modified On 23/07/2014 Post Graduate Thesis Type of Trial
Edmund Healthcare Pvt. Ltd.
+91-8048410921 Edmund Healthcare Pvt. Ltd. https://www.edmundhealthcare.in/ Our firm is ranked as the leading Trader and Supplier of a wide array of Pharmaceutical Injection, Pharmaceutical Tablets, Pharmaceutical
10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE
10 th SEC- (Reproductive & Urology)meetingheld on 16-01-2015 at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi 110 002 PROGRAMME SCHEDULE Recommendation:- The 10 th SEC (Reproductive and Urology) meeting
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Thu, 18 Oct 2018 14:39:26 GMT) CTRI Number Last Modified On 06/04/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Mon, 25 Mar 2019 20:33:33 GMT) CTRI Number Last Modified On 14/11/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
1. Dr. Shyam Agarwal, Joint Secretary, Department of Commerce. 2. Shri A.K. Bamba, Director, Department of Commerce
Minutes of Meeting of Inter Ministerial Committee (IMC) for consideration of proposals for setting up ICDs / CFSs held under Chairmanship of Shri P.K. Chaudhery, Additional Secretary (AS), Department of
Form IV-A Short-term Inter-State Transactions of Electricity by Trading Licensees ( RTC*)
Form IV-A Short-term Inter- Transactions of Electricity by Trading Licensees ( RTC*) Trading Licensee: Tata Power Trading Co. Ltd. Period of Power Delivery Start date (DD/MM/YYYY) End date (DD/MM/YYYY)
AGENDA PAPERS FOR THE EIGHTEENTH MEETING SUB-COMMITTEE ON LARGE ANIMALS (SCLA)
AGENDA PAPERS FOR THE EIGHTEENTH MEETING OF SUB-COMMITTEE ON LARGE ANIMALS (SCLA) DATE : 18.04.2005 TIME : 3 : 00 P.M. VENUE : 8 TH FLOOR, JEEVAN PRAKASH BUILDING, 25, KASTURBA GANDHI MARG, NEW DELHI.
Date: November 28, 2010 Edition: Bangalore. The Times of India
Date: November 28, 2010 Edition: Bangalore The Times of India Date: November 28, 2010 Edition: Bangalore The New Indian Express Date: November 28, 2010 Edition: Bangalore DNA Date: November 29, 2010 Edition:
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF SPTEMBER-2013 DATE OF HEARING 10.09.2013 R. T. M. 1. 842945/16 Rect. AMD-249059 Mr. Pankajbhai Sitaram Nayak, Hearing on Section
Central Inspection Plan Using Risk Based Approach Of Vaccine Manufacturing Units for 2017
, follow-up, failure A NORTH ZONE 1 M/s Biomed Pvt. Ltd, C-96, Site I, Bulandshahar Road, Ind. Area, Ghaziabad. 1. Oral Polio Vaccine IP, 2. Vi Typhoid Vaccine (Bio Typh TM ) IP, 3. Haemophilus Type-B
REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
Solvay in India January, 2014
Solvay in India January, 2014 SOLVAY in India, Innovation and Operational excellence Jodhpur Hichem (JV) Ahmedabad Hichem (JV) Bhiwani Hichem (JV) Delhi Hichem (JV) Solvay R&D center Vadodara Panoli Solvay
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Fri, 05 Oct 2018 20:16:50 GMT) CTRI Number Last Modified On 07/08/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023
Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023 Global Psoriasis Pipeline Drugs Industry Sizing, Growth and Forecast
Drug Information Centre (DIC)-An Indian Scenario
APTI Drug Information Centre (DIC)-An Indian Scenario 1 1 1 1 1 Nitesh S Chauhan, Firdous, R Raveendra, Geetha J, B Gopalakrishna, Roopa Karki 1 R R College of Pharmacy, Bangalore-560090, India Acharya
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
Disbursement of MDA Claims to Individual Exporters during (-11) 1 JPN Pharma API China 80,000.00 2 Unique Biotech Limited Bio May 3-6, 80,000.00 3 Titan Biotech Limited Cphi Japan 21st to 23rd April 80,000.00
What s New
What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related
Global Aspergillosis Drugs Market Professional Survey Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24
TABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
Doing Business in India; Nutritional ingredients supplier perspective. Jaime Piza DSM Nutritional Products November, 2012
Doing Business in India; Nutritional ingredients supplier perspective Jaime Piza DSM Nutritional Products November, 2012 Table of contents Doing business IFC classification. Still some hurdle to take...
Name of firm/applicant. Torrent Pharmaceuticals. Glenmark Pharmaceuticals. M/s. Torrent Pharmaceutical. Torrent Pharmaceuticals
Recommendation:- The 14 Th SEC (Cardiovascular & Renal) deliberated the proposals on 21.08.2014 and recommended the following:- Agenda no. File no Name of firm/applicant Recommendations 1. 04-228/06-D(pt
FROST & SULLIVAN. Publications Division - Terms and Conditions of Business
FROST & SULLIVAN Publications Division - Terms and Conditions of Business 1. Frost & Sullivan and FICCI takes no responsibility for any incorrect information supplied by manufacturers or users. Quantitative
Recommendations: Agend a no. Recommendations. Institute. New Drugs Division /12-DC ArbekacinSulphate Injection 200mg/4ml
: I approve the minutes of 32 nd SEC (Antimicrobial, Antiviral, Antiparasitic and Antifungal) held on 11.04.2017 at CDSCO HQ New Delhi and recommended the following: Agend New Drugs Division 1 12-34/12-DC
Drug Information services-an Emerging Practice in India A Review
Drug Information services-an Emerging Practice in India A Review Mukesh malik Pharmacy Department, Faculty of Shri Ram Murti Smarg College of Engineering, and Technology The UPT. University Uttar Pradesh,
INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2015 ADMISSION SESSION
Jubilee Hills, Hyderabad-34 Critical Care Medicine 3 Jubilee Hills, Hyderabad-34 Interventional Cardiology 1 Jubilee Hills, Hyderabad-34 Pediatric Cardiology 1 Care Hospital Road No. 1, Banjara Hills,
Pharmacologyonline 2: (2010) Newsletter Narain et al.
Drug Information Services An Emerging Practice In India Dr. P.J.Narain,Mukesh K. Malik*, Babita R.malik Pharmacy Department, Faculty of Shri Ram Murti Smarg College Engineering, Bareilly 243202, INDIA
Case 2:09-cv DMC-CCC Document 1 Filed 03/20/2009 Page 1 of 95. Of Counsel:
Case 2:09-cv-01302-DMC-CCC Document 1 Filed 03/20/2009 Page 1 of 95 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza Newark, NJ 07102 (973) 286-6700 clizza@saul.com Attorneys for Plaintiff
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Wed, 10 Oct 2018 02:19:24 GMT) CTRI Number Last Modified On 06/11/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Lamivudine Tablets 150 mg (Macleods Pharmaceuticals Ltd), HA424. WHOPAR Part 5 05/2011, version 1.0 LABELLING. Page 1 of 8
LABELLING Page 1 of 8 PARTICULARS TO APPEAR ON THE OUTER PACKAGING Bottle carton label 1. NAME OF THE MEDICINAL PRODUCT Lamivudine 150 mg Tablets * 2. STATEMENT OF ACTIVE SUBSTANCE Each film-coated tablet
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY
Dataset : PharmaTrac MAT MAY PharmaTrac Overview MAY 18
PharmaTrac Overview MAY 18 8434 8956 9655 10422 8112 8917 9549 8258 8921 9406 8668 9630 9381 8662 8373 8999 9013 9796 10413 8742 9315 10050 8458 9180 8601 9092 9767 8364 9145 10583 10173 10387 10217 10476
https://www.indiamart.com/max-pharma/
+91-8048603315 Max Pharma https://www.indiamart.com/max-pharma/ We are one of the leading organizations engaged in manufacturing and supplying a wide range of Pharmaceutical Drugs. These include Tablets,
REF/2013/04/ CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 22 Apr 2018 22:27:45 GMT) CTRI Number Last Modified On 09/10/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Varna Suraksha LXi12. Features of the System: Master Console. Specifications:
Varna Suraksha LXi12 Varna Suraksha Rodent Repellers - LXi12 Master Consoles are high frequency signal generators. These signals are fed to the transducers which in turn convert them into high frequency
Hyderabad, India Delegates. April 27, Tentative program A comprehensive Bioanalysis conclave. Key notes.
INTERNATIONAL CONFERENCE &EXHIBITION Tentative program A comprehensive Bioanalysis conclave 7+ Key notes 50+ Poster presentations 100+ Delegates 2 + Panel Discussions April 27, 2018 Hyderabad, India Invitation
INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION
Fortis Escorts Heart Institute Okhla Road, Delhi Cardiac Anaesthesia 3 New Delhi-25 G B Pant Hospital J L Nehru Marg, Delhi Cardiac Anaesthesia 2 Delhi-110002 Indraprastha s Sarita Vihar, Delhi Cardiac
REF/2014/04/ CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Wed, 02 May 2018 19:38:55 GMT) CTRI Number Last Modified On 13/12/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING (2ND ROUND) 2015 ADMISSION SESSION
Jubilee Hills, Hyderabad-34 Pediatric Cardiology 1 Care Hospital Road No. 1, Banjara Hills, Hyderabad - 34 Critical Care Medicine 1 Fernandez Hospital Pvt. Ltd. 4-1-1230, Bogulkunta, Hyderabad - 01 STAR
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Tue, 09 Apr 2019 14:50:06 GMT) CTRI Number Last Modified On 11/04/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION
Fortis Escorts Heart Institute Okhla Road, Delhi Cardiac Anaesthesia 3 New Delhi-25 G B Pant Hospital J L Nehru Marg, Delhi Cardiac Anaesthesia 2 Delhi-110002 Indraprastha s Sarita Vihar, Delhi Cardiac
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of s National Pricing Authority ORDER New
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 15 Dec 2018 04:51:20 GMT) CTRI Number Last Modified On 05/12/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
NOTIFICATION NO Different cooling off periods applicable for re-admission to Bureau membership - Publisher Members
Audit Bureau Of Circulations Founder Member : International Federation Audit Bureaux Circulations Wakefield House, Sprott Road, Ballard Estate, Mumbai 400 001 Tel: 2261 18 12 / 2261 90 72. Fax: 2261 88
Name of Hospital/ Institution State Speciality
03 admission session Jubilee Hills, Hyderabad-34 Jubilee Hills, Hyderabad-34 Hospital Road No., Banjara Hills, Hyderabad - 34 Hospital Road No., Banjara Hills, Hyderabad - 34 Fernandez Hospital Pvt. Ltd.
Report on Industrial Visit to Yakult Danone India (P) Ltd, HSIIDC Industrial Area, Rai, Sonepat, Haryana. Organized for. BBA-IV Sem-II Shift,
Report on Industrial Visit to Yakult Danone India (P) Ltd, HSIIDC Industrial Area, Rai, Sonepat, Haryana Organized for BBA-IV Sem-II Shift, Tecnia Institute Of Advanced Studies, Madhuban Chowk, Rohini,
Decisions taken in the 63 rd Meeting of the Genetic Engineering Approval Committee (GEAC) held on 8 th February 2006.
Decisions taken in the 63 rd Meeting of the Genetic Engineering Approval Committee (GEAC) held on 8 th February 2006. The 63 rd Meeting of the Genetic Engineering Approval Committee was held on 8 th February
Medicines availability short-term supply issues Last updated 01/05/18
Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
DEFERRED PROPOSALS OF THE LAST IMC MEETlNG HELD ON
.. " Minutes of the meeting of Inter Ministerial Committee OMC) for consideration of proposals of setting up of }CDs/CFSs held under the Chairm'aIiship of Shri Madhusudan Prasad, Additional Secretary Onfrastructure),
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Tue, 16 Apr 2019 09:11:00 GMT) CTRI Number Last Modified On 04/10/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study